EQUITY PURCHASE AGREEMENTEquity Purchase Agreement • June 18th, 2012 • NeoStem, Inc. • Services-misc health & allied services, nec
This Equity Purchase Agreement (this “Agreement”) is made and executed as of June 18, 2012 (the “Signing Date”), by and among Fullbright Finance Limited, a limited liability company organized under the laws of British Virgin Islands (“Fullbright”), Suzhou Erye Economy & Trading Co., Ltd., a limited liability company organized under the laws of the People’s Republic of China (“EET”; together with Fullbright, each a “Purchaser” and collectively, the “Purchasers”), NeoStem, Inc., a Delaware corporation whose shares of common stock are publicly traded in the United States (“NeoStem”), China Biopharmaceuticals Holdings, Inc., a Delaware corporation and a wholly owned subsidiary of NeoStem (the “Seller”; together with NeoStem, each a “Seller Party” and collectively, the “Seller Parties”), and Suzhou Erye Pharmaceutical Co., Ltd., a Sino-foreign equity joint venture with limited liability organized under the laws of the People’s Republic of China (the “Company”; together with the Purchasers a
